Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05151367
Other study ID # AAAT1572
Secondary ID 1R21CA253604-01
Status Completed
Phase N/A
First received
Last updated
Start date February 23, 2022
Est. completion date December 31, 2022

Study information

Verified date March 2023
Source Columbia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic, also in Kampala. While text messages can be used in populations with low literacy, families can opt to receive automated phone call reminders instead. The investigators will pilot assess the impact of vaccine reminders on human papillomavirus (HPV) vaccination. Caregivers of preteens/adolescents will be randomized and stratified by site, language and HPV vaccine dose needed (initiation vs. completion). As this is a feasibility trial, the investigators expect to measure effect size but not necessarily achieve statistical significance.


Description:

Cervical cancer is the leading female cancer in Uganda. Many women are diagnosed with late-stage disease, and 80% of women die within 5 years of diagnosis, making primary prevention critical. HPV is the principal cause of cervical cancer, making vaccination the single most important primary preventive measure. The national HPV vaccination program in Uganda began in November 2015 and focuses solely on preteen/adolescent girls. Two strategies have been adopted for the multi-dose series: 1) school-based and 2) community-based. However, in Kampala, only 29% of girls receive both needed doses. Reasons for undervaccination include school absenteeism on special vaccination days for those receiving vaccination as part of a school program, failing to remember to come to a health facility for a needed dose for those being vaccinated in the community, and lack of knowledge regarding HPV and the vaccines including vaccine misperceptions. While research regarding the use of text message vaccine reminders is strong in the U.S., their use has not yet been demonstrated in a preteen/adolescent population in Sub-Saharan Africa and other low and middle income countries (LMICs). According to the World Bank, currently 89.9% of urban households in Uganda have a cell phone.


Recruitment information / eligibility

Status Completed
Enrollment 154
Est. completion date December 31, 2022
Est. primary completion date October 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 10 Years to 14 Years
Eligibility Inclusion Criteria: - Be a parenting adult of an adolescent girl aged 10-14 years - Reside in Kampala and/or the surrounding districts - Speak English or Luganda - Have a cell phone with text messaging capability - Must have ability to consent Exclusion Criteria: - Parenting adult speaks other language than English or Luganda only - Parenting adult already enrolled in the study for another child - Participation in pretesting activities

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Text message reminder
Receipt of text messages notifying when the next HPV vaccine dose is due (either first or second)

Locations

Country Name City State
Uganda Makerere University/Mulago Hospital Kampala
United States Columbia University Irving Medical Center New York New York

Sponsors (3)

Lead Sponsor Collaborator
Columbia University Makerere University, National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Uganda, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to Receipt of Next HPV Vaccine Dose Timeliness of vaccination (time to event) will be measured. Up to 6 months from randomization
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05658198 - Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi
Completed NCT05804825 - Testing the Persuasiveness of Pro-inoculation Arguments N/A
Enrolling by invitation NCT03592225 - Can an Educational Intervention Targeting General Practitioners Increase HPV Vaccination Coverage in AuRA_Lyon (France) N/A
Completed NCT04576962 - County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana
Completed NCT01284374 - Parent-son-provider Decision-making About HPV Vaccination N/A
Recruiting NCT06161831 - HPV Vaccine Reminders - SEARCH II Study N/A